These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 7851026)

  • 41. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells.
    Re F; Mengozzi M; Muzio M; Dinarello CA; Mantovani A; Colotta F
    Eur J Immunol; 1993 Feb; 23(2):570-3. PubMed ID: 8436189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.
    Marsh CB; Wewers MD
    Am J Respir Cell Mol Biol; 1994 May; 10(5):521-5. PubMed ID: 8179914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells.
    Goletti D; Kinter AL; Hardy EC; Poli G; Fauci AS
    J Immunol; 1996 May; 156(9):3501-8. PubMed ID: 8617979
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monocyte cytokine production in an elderly population: effect of age and inflammation.
    Roubenoff R; Harris TB; Abad LW; Wilson PW; Dallal GE; Dinarello CA
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M20-6. PubMed ID: 9467429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.
    Hart PH; Whitty GA; Piccoli DS; Hamilton JA
    J Immunol; 1988 Sep; 141(5):1516-21. PubMed ID: 3137258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C; Strober W
    J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy.
    Shu KH; Lee SH; Cheng CH; Wu MJ; Lian JD
    Kidney Int; 2000 Aug; 58(2):783-9. PubMed ID: 10916103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Whole blood production of monocytic cytokines (IL-1beta, IL-6, TNF-alpha, sIL-6R, IL-1Ra) in haemodialysed patients.
    Le Meur Y; Lorgeot V; Aldigier JC; Wijdenes J; Leroux-Robert C; Praloran V
    Nephrol Dial Transplant; 1999 Oct; 14(10):2420-6. PubMed ID: 10528667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic effects of IL-4 and either GM-CSF or IL-3 on the induction of CD23 expression by human monocytes: regulatory effects of IFN-alpha and IFN-gamma.
    Alderson MR; Armitage RJ; Tough TW; Ziegler SF
    Cytokine; 1994 Jul; 6(4):407-13. PubMed ID: 7948749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells.
    Rambaldi A; Torcia M; Bettoni S; Vannier E; Barbui T; Shaw AR; Dinarello CA; Cozzolino F
    Blood; 1991 Dec; 78(12):3248-53. PubMed ID: 1835893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor.
    Randow F; Döcke WD; Bundschuh DS; Hartung T; Wendel A; Volk HD
    J Immunol; 1997 Mar; 158(6):2911-8. PubMed ID: 9058829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IL-1 receptor antagonist (IL-1ra) expression, function, and cytokine-mediated regulation during mycobacterial and schistosomal antigen-elicited granuloma formation.
    Ruth JH; Bienkowski M; Warmington KS; Lincoln PM; Kunkel SL; Chensue SW
    J Immunol; 1996 Apr; 156(7):2503-9. PubMed ID: 8786311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
    Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
    Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monokines: stimulatory and inhibitory regulator molecules of myelopoiesis in vitro.
    Oster W; Lindemann A; Riedel D; Cicco NA; Mertelsmann R; Herrmann F
    J Biol Regul Homeost Agents; 1988; 2(3):134-8. PubMed ID: 2474236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis.
    Matsuo K; Ikizler TA; Hoover RL; Nakamoto M; Yasunaga C; Pupim LB; Hakim RM
    Kidney Int; 2000 Feb; 57(2):697-708. PubMed ID: 10652049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10.
    de Waal Malefyt R; Figdor CG; Huijbens R; Mohan-Peterson S; Bennett B; Culpepper J; Dang W; Zurawski G; de Vries JE
    J Immunol; 1993 Dec; 151(11):6370-81. PubMed ID: 7902377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.
    Alvaro-Gracia JM; Zvaifler NJ; Firestein GS
    J Clin Invest; 1990 Dec; 86(6):1790-8. PubMed ID: 2174906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.